A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis
Public ClinicalTrials.gov record NCT06238817. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or are intolerant to, or contraindicated to topical corticosteroid (TCS)s and topical calcineurin inhibitor (TCI)s.
Study identification
- NCT ID
- NCT06238817
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 241 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 26, 2024 (Actual)
- Primary completion
- May 21, 2025 (Actual)
- Completion
- Oct 17, 2025 (Actual)
- Last update posted
- Oct 15, 2026
2024 – 2025
United States locations
- U.S. sites
- 18
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lynn Institute of the Ozarks | Little Rock | Arkansas | 72204 | — |
| First Oc Dermatology | Fountain Valley | California | 92708 | — |
| Center For Dermatology Cosmetic and Laser Surgery | Fremont | California | 94538 | — |
| Medderm Associates, Inc | San Diego | California | 92103 | — |
| Encore Medical Research, Llc Hollywood | Hollywood | Florida | 33021 | — |
| Entrust Clinical Research | Miami | Florida | 33176 | — |
| Lane Dermatology and Dermatologic Surgery | Columbus | Georgia | 31904 | — |
| Marietta Dermatology the Skin Cancer Center Marietta | Marietta | Georgia | 30060 | — |
| Arlington Dermatology | Rolling Meadows | Illinois | 60008 | — |
| Northshore University Healthsystem | Skokie | Illinois | 60077 | — |
| Oakland Hills Dermatology Pc | Auburn Hills | Michigan | 48326 | — |
| Revival Research Institute, Llc Troy | Troy | Michigan | 48084 | — |
| Best Skin Research | Camp Hill | Pennsylvania | 17011 | — |
| International Clinical Research Tennessee Llc | Murfreesboro | Tennessee | 37130 | — |
| Center For Clinical Studies Webster | Houston | Texas | 77004 | — |
| Texas Dermatology Research Center | Plano | Texas | 75025 | — |
| Rainey and Finklea Dermatology | San Antonio | Texas | 78213 | — |
| North Sound Dermatology | Mill Creek | Washington | 98012 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06238817, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06238817 live on ClinicalTrials.gov.